Table 1.

Summary of clinical characteristics of four patients with WAS gene mutation with large vessel vasculopathy in our cohort

Patient 1Patient 2Patient 3Patient 4
Age of presentation 5 years 3.5 years 11 years 11.8 years 
Age of onset of initial symptoms Infancy 2 years 8 years 11.4 years 
Age at diagnosis of WAS 5 years 3.5 years 11 years 11.8 years 
Age at the time of vasculitis manifestations 16 years 10 years 11 years 11.4 years 
Presenting complaints Acute febrile encephalopathy, seizures, right-sided lower motor neuron facial nerve palsy, bilateral lateral rectus palsy Recurrent abdominal pain Polyarthritis, recurrent abdominal pain, cough, hypertension, cardiac dysfunction Abdominal pain, neck pain, left upper limb claudication 
Lymphoproliferation Present Present Present Absent 
Past infections 
Bacterial infections Sinopulmonary infections, pyogenic meningitis, pulmonary Tuberculosis Sinopulmonary infections None None 
Viral infections None Warts, extensive molluscum contagiosum None None 
Autoimmune manifestations, if any DCT negative autoimmune hemolytic anemia Autoimmune hemolytic anemia Arthritis, ANA negative, DCT negative None 
Eczema ++ ++ − − 
IVIg prophylaxis at the time of vasculitis Noncompliant Noncompliant Not initiated Not initiated 
EBV viral load 9720 copies/ml 38,880 copies/ml Negative 5200 copies 
CMV PCR, Serology:(HIV, HSV, HCV) and HBsAg Negative Negative Negative Negative 
Investigations 
MPV (fl) 6.7 6.8 7.4 6.1 
Lowest platelet counts at presentation with vasculitis (×109/L) 2.9 35 69 136 
Immunoglobulin profile 
IgG (g/L) (N:5–16) 12.4 7.5 6.67 14.9 
IgM (g/L) (N:0.5–2) 1.35 0.24 0.47 0.50 
IgA (g/L) (N:0.4–2) 0.59 5.68 1.92 5.83 
IgE (KU/L; N<100) 370 6720 786 1256 
Lymphocyte Subset analysis 
CD3+ T lymphocytes (N: 55–75%) 61.9% 76.64% 56.9% 86.5% 
CD19+ B lymphocytes (N: 10–30%) 7.6% 4.99% 30.58% 5.09% 
CD16/56+ NK cells (N:4–23%) 7.3% 10.69% 11.81% 7.14% 
CD3+ CD4+ T cell (N:27–53%) 36.25% 36.25% 69.75% 71.6% 
CD3+ CD8+ T cell (N: 19–34%) 55.97% 55.97% 21.14% 19.4% 
CD4:CD8 ratio (N: 0.9–3.6) 0.65 0.65 3.3 4.1 
CD4+ CD127 CD25+ (Tregs) (N: 5–10%) 4% 4% 14.45% 8.8% 
WAS protein expression 
Delta MFI Patient: 1200 Patient: 281 Patient: 1495 Patient: 5128 
Control: 4300 Control: 1087 Control: 4761 Control: 7875 
Stain index Patient: 4 Patient: 4.17 Patient: 159 Patient: 145.46 
Control: 15.33 Control 8.68 Control: 428 Control: 65.68 
WAS protein Reduced Reduced Reduced Normal 
WAS gene variant c.1021+2T>G, Intron 10-IVS 10+2 T>G Exon 1 c.37C>T; p.R13* Exon 2 c.256C>T, p.Arg86Cys Exon 1 c.103 C>T, p.Leu35Phe 
Arterial involvement Thoracic and suprarenal part of abdominal aorta, critical focal luminal narrowing of brachiocephalic trunk at its origin with complete luminal occlusion of left subclavian artery and left common carotid artery Abdominal aorta extending from diaphragmatic hiatus to bifurcation (L5 vertebral level). Variable length of proximal coeliac trunk, superior mesenteric artery and left renal artery showed fusiform dilatations Suprarenal and renal segments and short infrarenal segment of the abdominal aorta, celiac artery origin, anterior right renal artery, posterior right renal artery Long segment occlusion / tight stenosis of left subclavian artery. 

Bold values indicate abnormal values.

N, age related normal values; WAS, Wiskott Aldrich syndrome; DCT, direct coombs test; fl, femtoliter; ANA, Anti nuclear antibody; IVIg, intravenous immunoglobulin; NK cell, natural killer cells, Tregs, Regulatory T cells; MFI, mean fluorescence index; EBV, Epstein barr virus; PCR, polymerase chain reaction, HIV-Human immunodeficiency virus; HSV, herpes simplex virus; HCV, Hepatitis C Virus; HBsAg, Hepatitis B surface antigen.

or Create an Account

Close Modal
Close Modal